跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT04634305
NCT04634305Unknown不适用

Evaluation of the Clinical and Functional Results Obtained After a Total Elbow Arthroplasty, All Indications Combined

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2004年1月1日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
发起方
入组人数
45
试验地点
1
主要终点
QuickDASH
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Analysis of clinical and functional outcomes after a total elbow arthrosplasty, all indications combined, with a minimum follow up of 24 months The hypothesis is that there a significant improvement after an elbow replacement, no matter what the surgery indication is

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —（Adult, Older Adult）
性别
All
接受健康志愿者
否

入选标准

  • •Total elbow arthroplasty, all indication combined

排除标准

  • •Less than 24 months of follow up
  • •Revision of total elbow arthroplasty

结局指标

主要结局

QuickDASH

时间窗: through study completion, an average of 5 years

Mayo Elbow Performance Score

时间窗: through study completion, an average of 5 years

Range of motion

时间窗: through study completion, an average of 5 years

次要结局

  • Triceps deficiency(through study completion, an average of 5 years)
  • Bushing wear(through study completion, an average of 5 years)
  • Implant loosening(through study completion, an average of 5 years)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

François SIRVEAUX

Clinical Professor François Sirveaux

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验

终止
不适用
Uncemented Total Elbow Arthroplasty Data CollectionTotal Elbow Arthroplasty
NCT00974298Vanderbilt University2
终止
不适用
Total Knee Arthroplasty Functional Outcomes Study Research DesignOsteoarthritis of the Knee
NCT02228538Restor3D7
进行中（未招募）
不适用
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 18.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 18.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853
EUCTR2013-005464-25-FRAlcon Research, Ltd.474
进行中（未招募）
不适用
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 16.1Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 16.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853
EUCTR2013-005464-25-ESAlcon Research, Ltd.474
进行中（未招募）
不适用
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 17.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 17.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853
EUCTR2013-005464-25-PLAlcon Research, Ltd.474